Merck receives demand notice from NPPA for overcharging syrup formulation

31 Dec 2016 Evaluate

Merck has received a demand notice from National Pharmaceutical Pricing Authority (NPPA) demanding a sum of Rs 11.68 crore plus interest Rs 15.78 crore alleging overcharging of price of the formulation, Polybion L 100 ML syrup, during the period from January 2006 to June 2009.

The government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug. The company will challenge the said orders and will defend itself vigorously. The company has been legally advised it has a good defendable case on merits.

Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments - Pharmaceuticals and Chemicals.


Procter&Gamble Healt Share Price

5632.90 -4.35 (-0.08%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×